scholarly journals SUN-LB064 A Phase 2, Dose-Escalation, Safety and Efficacy Study of Tildacerfont (SPR001) for the Treatment of Patients with Classic Congenital Adrenal Hyperplasia

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Kyriakie Sarafoglou ◽  
Ron Newfield ◽  
Maria Vogiatzi ◽  
Erik Imel ◽  
A. Odugbesan ◽  
...  
Author(s):  
Núbia Maria de Oliveira ◽  
Raquel David Langer ◽  
Sofia Helena Valente de Lemos-Marini ◽  
Gil Guerra-Júnior ◽  
Ezequiel Moreira Gonçalves

Sign in / Sign up

Export Citation Format

Share Document